about
Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD)Clinical trials of dendritic cell-based cancer vaccines in hematologic malignanciesAnti-cancer vaccines - a one-hit wonder?The Evolving Role of Immune Checkpoint Inhibitors in Cancer TreatmentHapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunityHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferB-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cellsOpportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer TreatmentAddressing current challenges in cancer immunotherapy with mathematical and computational modelling.The natural product phyllanthusmin C enhances IFN-γ production by human NK cells through upregulation of TLR-mediated NF-κB signaling.Enhanced CD8 T cell responses through GITR-mediated costimulation resolve chronic viral infection.Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.A therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer.Natural killer cells: role in local tumor growth and metastasisAbrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo2015 Guidance on cancer immunotherapy development in early-phase clinical studies.Personalized peptide vaccination: a novel immunotherapeutic approach for advanced cancerNK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by CytokinesEmerging cancer vaccines: the promise of genetic vectors.Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.Activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor CTL responses leading to tumor regressionApoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized miceCancer vaccines inducing antibody production: more pros than cons.Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses.Melanoma as a model tumour for immuno-oncology.Clinical trials in cellular immunotherapy for brain/CNS tumors.Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection.Myasthenia gravis and risks for comorbidity.Dendritic cell-based vaccine research against cancer.Immunotherapy of melanoma: present options and future promises.Adoptive Cell Therapy in Multiple Myeloma.Immunotherapy in prostate cancer: challenges and opportunities.Is autoimmunity the Achilles' heel of cancer immunotherapy?Applying Subtractive Hybridization Technique to Enrich and Amplify Tumor-Specific Transcripts of Esophageal Squamous Cell Carcinoma.Dendritic cell vaccination in melanoma patients: From promising results to future perspectivesPembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient CasesCell-Based Biohybrid Drug Delivery Systems: The Best of the Synthetic and Natural Worlds.Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.Characterization of Ewing sarcoma associated cancer/testis antigens
P2860
Q26749007-BFB49DD6-E1B1-47F6-B15E-B90161F12F56Q26864603-C168D33D-8B73-4275-80F6-AEED7A614C20Q26995164-A42A6339-8243-4C29-B6DA-876E98F0080DQ27022789-BEBE3DA3-A58C-4B1E-AF4A-936D0D5256D3Q28387629-7EC3D3E9-484F-4810-AB76-5BE25DA01E8EQ28727481-C3330C3B-7290-455D-BDA3-68DE08DDA5BAQ29620717-F4132AFC-7B04-4881-8351-5A528DE2CCD3Q33658400-F047B13E-97F3-459A-89E4-13E2F9E8B7AAQ33718182-2DC8BD03-E86A-4BEB-AF60-92F8ECA71A47Q33861540-3E225C71-8DBE-4743-B347-B92DAECAC1CEQ34171983-86803C8F-0BF1-4BEC-89BE-9D6AD3E7303EQ35147454-879A8B1F-7C46-427F-8B2E-6BB48F45DB38Q35300659-FAC6379D-C5B9-46E7-994D-77649C37F517Q35318315-B151543E-54D2-49DD-8B28-2130E0B26B7AQ35905953-9F1A82C7-9F0E-45F1-B0DC-47625C9A1520Q36466018-BA3751E8-907C-464F-9A25-21B66F3592EDQ36467378-5FC86231-00D1-40B2-B4C9-838FCE670BA9Q36631314-6F42BA74-C553-4BEC-A9F6-15516E195B9EQ36759187-3AA4AD5C-8D2B-44AA-AF19-4C73DC83A5FDQ37137464-C3AA6258-F950-4450-8CBB-ECE5B4D93319Q37404065-3FB5C3C3-E512-4F67-A57B-A272ADC4344FQ37457716-D36B55B4-8E9D-4F12-ABFB-7AEF10E5BB3EQ37725761-D75D499D-4F23-4CAE-96B9-E3687DD0D9C3Q37932519-106FAE00-89AC-4159-A016-C09CC540B473Q37963294-D4C7E90F-625D-4381-8AC8-AB3EA46F2887Q38037486-3D12B930-7D0E-4B94-98A3-D1A4FB3BDE8AQ38094811-790C4DCE-D7FF-4485-9062-3B56C8C32C82Q38144256-0B3F6021-6278-4418-9BF5-32A8F9F9C797Q38263703-BB2DD0AE-1966-4D92-86B9-78C6D567C2BBQ38281782-C183E339-44E0-455E-94B3-DA4E8EF44491Q38318683-63421658-7553-4A4F-9187-549505EED83EQ38635138-BCF27FEC-8E7B-47D4-8F8F-B03D9CD6FD6DQ38661079-E18B5FC5-876B-427E-8A57-6F3705E1A573Q38687375-866E4687-49A8-4442-93C6-C9D9F0FF06A2Q38841320-E2908E29-2DCE-4624-80DE-9E72C3FEA745Q38850950-2CFFA452-63D4-4503-8467-D26F95225732Q39003398-D8361453-B52C-4509-9488-709DC1A85D16Q39031369-80ACB79A-A992-4C07-99E9-B6815E667E27Q39113639-B07F4FD8-2453-40F1-868E-1A6E222438DDQ39215865-8FC222DF-AB50-4D8A-85D3-FB28142BD838
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmunity associated with immunotherapy of cancer.
@en
Autoimmunity associated with immunotherapy of cancer.
@nl
type
label
Autoimmunity associated with immunotherapy of cancer.
@en
Autoimmunity associated with immunotherapy of cancer.
@nl
prefLabel
Autoimmunity associated with immunotherapy of cancer.
@en
Autoimmunity associated with immunotherapy of cancer.
@nl
P2093
P1433
P1476
Autoimmunity associated with immunotherapy of cancer.
@en
P2093
Connie P M Duong
David S Ritchie
Jennifer A Westwood
Michael H Kershaw
Phillip K Darcy
Richard P Junghans
Sally M Amos
P304
P356
10.1182/BLOOD-2011-01-325266
P407
P577
2011-04-29T00:00:00Z